ANDREA LUNDQUIST: Open Payments
NPI 1154034577 · WHITE HOUSE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$143 in 8 payments from 7 companies in 2025. Trend: 2023 $1,417 · 2024 $579 · 2025 $143
Food & beverage: $143
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 2 | $37 |
| ABBVIE INC. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: XYOSTED, QULIPTA, REXULTI, Ozempic, CAPLYTA, KRYSTEXXA, AZMIRO.
Industry payments across TN — which companies pay providers there.
